STAT+: Mirati’s KRAS-blocking lung cancer drug clears safety hurdle in combination...
Mirati Therapeutics said Monday that its KRAS-targeting cancer drug called adagrasib combined with another immunotherapy was well-tolerated by patients with lung cancer —...
14 CIC Members’ Milestone Moments of 2022 — CIC
Founded by Brown undergrads in 2019, Providence-based Intus Care is helping health care providers deliver the best possible care to elderly patients. Intus’s...
FASHION WEEK
DON'T MISS
GADGET WORLD
STAT+: Mirati’s KRAS-blocking lung cancer drug clears safety hurdle in combination...
Mirati Therapeutics said Monday that its KRAS-targeting cancer drug called adagrasib combined with another immunotherapy was well-tolerated by patients with lung cancer —...
LATEST REVIEWS
STAT+: Mirati’s KRAS-blocking lung cancer drug clears safety hurdle in combination...
Mirati Therapeutics said Monday that its KRAS-targeting cancer drug called adagrasib combined with another immunotherapy was well-tolerated by patients with lung cancer —...
RECENT COMMENTS